Clinical Trials Directory

Trials / Conditions / Tuberculosis (TB)

Tuberculosis (TB)

37 registered clinical trials studyying Tuberculosis (TB)22 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPrevention and Mass Screening of TB in Prisons in Paraguay
NCT07520448
Universidad Nacional de CaaguazuN/A
Not Yet RecruitingTB SCReening Improves Preventive Therapy Uptake in Pregnant Women With HIV
NCT07278453
University of California, San FranciscoN/A
Not Yet RecruitingBurden of Tuberculosis Among Pregnant and Postpartum Women in Guinea-Bissau
NCT07419568
Aarhus University HospitalN/A
Not Yet RecruitingEffectiveness of Chat-based Mobile Application for Consultation (Zalo) in Improving Compliance With Follow-up
NCT07234929
Gia Dinh People HospitalN/A
Not Yet RecruitingOptimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through
NCT07163143
University College, LondonPhase 3
Not Yet RecruitingIntegrating HIV Prevention With TB Household Contact Evaluation in Uganda
NCT07119359
University of WashingtonN/A
RecruitingRespiratory Health and Wellbeing Post Pulmonary Tuberculosis
NCT07178860
Liverpool School of Tropical Medicine
RecruitingEffectiveness of Computer-Aided Detection Chest X-Ray Screening for Improving Tuberculosis Diagnostic Yield in
NCT06963606
Xuelin YangN/A
RecruitingQuestioning the Epidemiology of Asymptomatic TB
NCT07312266
Barcelona Institute for Global Health
Not Yet RecruitingComparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous D
NCT07058090
Liaquat National Hospital & Medical CollegePhase 1
Not Yet RecruitingTuberculosis in Rural and Malnourished Populations
NCT06971952
University of VirginiaN/A
RecruitingPRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment
NCT07024836
University College, London
RecruitingA Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease
NCT06909799
The Aurum Institute NPCN/A
RecruitingPharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence
NCT07069387
University of MalayaN/A
RecruitingESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
NCT06796647
Chinese University of Hong Kong
RecruitingExamining Psycho-Socioeconomic Linkages in TB Care: The UPLIFT Trial
NCT06916962
Freundeskreis Für Internationale Tuberkulosehilfe e.VN/A
RecruitingSafety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolesce
NCT06997367
Bharat Biotech International LimitedPhase 2
RecruitingA Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB
NCT06272812
International AIDS Vaccine InitiativePhase 2
CompletedCardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis
NCT07003581
B.P. Koirala Institute of Health Sciences
RecruitingEvaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
NCT06700876
Mahidol University
CompletedButterfly Pea Flower (Clitoria Ternatea) for Adjuvant TB Treatment
NCT06794502
Universitas Muhammadiyah SemarangEARLY_Phase 1
RecruitingGene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis
NCT06484530
Mahidol UniversityPhase 4
CompletedThe Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront
NCT07167823
University of Health Sciences Lahore
RecruitingPatients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
NCT06764576
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RecruitingResearch on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculo
NCT06702774
University of TorontoN/A
CompletedTuberculosis (TB) Aftermath
NCT04333485
Johns Hopkins UniversityN/A
WithdrawnQuantiFERON Access Clinical Performance Study Protocol
NCT04243031
QIAGEN Gaithersburg, Inc
CompletedSix-months Versus Nine-months ATT for Ocular TB
NCT06613919
L.V. Prasad Eye InstitutePhase 4
CompletedXpert MTB/RIF Ultra Trial
NCT07135622
Nestani TukvadzeN/A
CompletedAssessing the Ability of the T-SPOT®.TB Test
NCT03929705
Oxford Immunotec
UnknownInnovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections
NCT03808636
St George's, University of London
CompletedPhase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adult
NCT01879163
University of OxfordPhase 1
UnknownDiagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/
NCT01875952
Instituto Nacional de Salud Publica, MexicoPhase 4
CompletedImmunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Reg
NCT00600782
GlaxoSmithKlinePhase 2
CompletedSafety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-posit
NCT00146744
GlaxoSmithKlinePhase 2
CompletedSafety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negati
NCT00291889
GlaxoSmithKlinePhase 1
CompletedSafety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults
NCT00730795
GlaxoSmithKlinePhase 1